CVE-2022-30297

Description

Cross-site scripting in the Intel(R) EMA software before version 1.8.0 may allow a privileged user to potentially enable escalation of privilege via local access.

Category

3.8
CVSS
Severity: Low
CVSS 3.1 •
EPSS 0.06%
Vendor Advisory intel.com
Affected: n/a Intel(R) EMA software
Published at:
Updated at:

References

Link Tags
https://www.intel.com/content/www/us/en/security-center/advisory/intel-sa-00716.html vendor advisory

Frequently Asked Questions

What is the severity of CVE-2022-30297?
CVE-2022-30297 has been scored as a low severity vulnerability.
How to fix CVE-2022-30297?
To fix CVE-2022-30297, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2022-30297 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2022-30297 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2022-30297?
CVE-2022-30297 affects n/a Intel(R) EMA software.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.